Giufrè, M.; Errico, G.; Del Grosso, M.; Pagnotta, M.; Palazzotti, B.; Ballardini, M.; Pantosti, A.; Meledandri, M.; Monaco, M.
Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol. Antibiotics 2024, 13, 507.
https://doi.org/10.3390/antibiotics13060507
AMA Style
Giufrè M, Errico G, Del Grosso M, Pagnotta M, Palazzotti B, Ballardini M, Pantosti A, Meledandri M, Monaco M.
Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol. Antibiotics. 2024; 13(6):507.
https://doi.org/10.3390/antibiotics13060507
Chicago/Turabian Style
Giufrè, Maria, Giulia Errico, Maria Del Grosso, Michela Pagnotta, Bernardetta Palazzotti, Milva Ballardini, Annalisa Pantosti, Marcello Meledandri, and Monica Monaco.
2024. "Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol" Antibiotics 13, no. 6: 507.
https://doi.org/10.3390/antibiotics13060507
APA Style
Giufrè, M., Errico, G., Del Grosso, M., Pagnotta, M., Palazzotti, B., Ballardini, M., Pantosti, A., Meledandri, M., & Monaco, M.
(2024). Detection of KPC-216, a Novel KPC-3 Variant, in a Clinical Isolate of Klebsiella pneumoniae ST101 Co-Resistant to Ceftazidime-Avibactam and Cefiderocol. Antibiotics, 13(6), 507.
https://doi.org/10.3390/antibiotics13060507
